about
Hepatitis B virus reactivation with a rituximab-containing regimenPharmacokinetics and tolerability of human mouse chimeric anti-CD22 monoclonal antibody in Chinese patients with CD22-positive non-Hodgkin lymphoma.Fatal hepatitis B reactivation treated with entecavir in an isolated anti-HBs positive lymphoma patient: a case report and literature reviewBeyond tumor necrosis factor inhibition: the expanding pipeline of biologic therapies for inflammatory diseases and their associated infectious sequelae.B Cell Therapies, Approved and Emerging: a Review of Infectious Risk and Prevention During Use.Comparative Risk of Cardiovascular Outcomes Between Topical and Oral Nonselective NSAIDs in Taiwanese Patients With Rheumatoid Arthritis.
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Rituximab administration and reactivation of HBV.
@en
type
label
Rituximab administration and reactivation of HBV.
@en
prefLabel
Rituximab administration and reactivation of HBV.
@en
P2093
P2860
P356
P1476
Rituximab administration and reactivation of HBV.
@en
P2093
Junji Tanaka
Masahiro Asaka
Masahiro Imamura
Reiki Ogasawara
Shinichi Ito
Yoshiya Yamamoto
Yusuke Kamihara
Yutaka Tsutsumi
P2860
P304
P356
10.1155/2010/182067
P577
2010-12-01T00:00:00Z